RESOURCES

Use Cases

How Pharma & Agencies put the signals to work

Blogs

Intelligence at the intersection of data science and real-life health

The Talking Room

Demystifying AI, LLMs and machine learning

Compliance Hub

Data integrity, ethical AI and regulatory standards

DrugVoice

Built to be defensible.

Compliance, ethics, and data integrity are part of the process.

TMLABS

About TMLabs

Where our proprietary models are trained, tested and refined

Articles & scientific publications

Methodologies and validated outcomes

Latest paper

Understanding Unstructured Consumer Conversations in the GLP-1 Space

Articles & Scientific Publications

DRUGVOICE

DrugVoice

Measure how your messaging lands and evidence change

SEE IT IN ACTION

Challenge us!

See which messages resonate with different audiences, understand why, and where relevant, examine their association with intent-to-prescribe.

ABOUT US

About us

Our story, our mission and the people behind it

ESG

Responsible innovation and ethical data practice

WHO WE ARE

Challenge us!

A team built around one problem: making real-life conversation usable at scale.

Article

Classifying Patient and Professional Voice in Social Media Health Posts: Understanding the Power of Words

Feb 29, 2024

← All articles

In this article

Share

Understanding the Power of Words

 

Illuminate the true potential of words in healthcare with Talking Medicines, the global leader in patient intelligence. Through our advanced models and data science methodologies, we shed light on the vital importance of patient and healthcare professional voices. Experience the gold standard in understanding patient insights and empowering healthcare decision-making. Through analyzing social media, we capture the voice of the patient, painting a comprehensive picture of patients and their ecosystems. Join us in improving health outcomes by harnessing the true power of patient and healthcare professional voices.

 

Background 

 

Patient-based analysis of social media is a growing research field with the aim of delivering precision medicine, but it requires accurate classification of posts relating to patients’ experiences. We motivate the need for this type of classification as a pre-processing step for further analysis of social media data in the context of related work in this area. In this paper we present experiments for a three-way document classification by patient voice, professional voice or other. We present results for our proprietary model classifiers on English data from two difference data sources and two domains (cardiovascular and skin diseases).

 

Conclusion 

 

The main conclusion resulting from this work is that using more data for training a classifier does not necessarily result in best possible performance. In the context of classifying social media posts by patient and professional voice, we showed that it is best to train separate models per data source instead of a model using the combined training data from both sources. We also found that it is preferable to train separate models per domain (cardiovascular and skin) while showing that the difference to the combined model is only minor (0.01 accuracy). Our highest overall F1-score (0.95) obtained for classifying posts as patient voice is a very good starting point for further analysis of social media data reflecting the experience of patients.

 

Acknowledgements

We would like to thank the Talking Medicines Limited annotators who worked extremely hard to create the data needed for model training and validation.

 To read the full article follow the link below:

BMC Medical Informatics and Decision Making 

Authors: Beatrice Alex, Donald Whyte, Daniel Duma, Roma English Owen, and Elizabeth A.L. Fairley.

 

Stay ahead of message impact

Know which messages change behaviour, before the prescriptions are written.

Transforming millions of real-life conversations into curated intelligence.

Evidence-led insights powered by DrugVoice and the Message Resonance™ Score. Roughly two a fortnight, straight from the teams building the models.

Subscribe on LinkedInFollow Talking Medicines

Keep reading

More from the same topic.

Loading...